| Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib | |
| He, Yueming; Sheng, Wang; Hu, Weiguo; Lin, Jing; Liu, Junjun; Yu, Bing; Mao, Xinru; Zhang, Lu; Huang, Jin; Wang, Guangsuo | |
| 刊名 | ONCOLOGY RESEARCH
 |
| 2019 | |
| 卷号 | 27期号:8 |
| 关键词 | ROS1 fusion Crizotinib Non-small-cell lung cancer (NSCLC) |
| ISSN号 | 0965-0407 |
| DOI | 10.3727/096504019X15509372008132 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4214946 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | He, Yueming,Sheng, Wang,Hu, Weiguo,et al. Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib[J]. ONCOLOGY RESEARCH,2019,27(8). |
| APA | He, Yueming.,Sheng, Wang.,Hu, Weiguo.,Lin, Jing.,Liu, Junjun.,...&Wang, Guangsuo.(2019).Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib.ONCOLOGY RESEARCH,27(8). |
| MLA | He, Yueming,et al."Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib".ONCOLOGY RESEARCH 27.8(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论